INCY
INCYTE CORP
NASDAQ · Healthcare · Biotechnology · US
$125.31
−1.81%Forward multiples
Based on analyst estimates
- P/E forward
- 43.26x
- P/E 2026E
- 33.90x
- P/E 2027E
- 14.93x
- P/E 2028E
- 14.03x
- P/S forward
- 4.29x
Trailing multiples
Trailing twelve months
- P/E TTM
- 15.41x
- PEG TTM
- 0.25x
- Price / book
- 4.00x
- Price / sales
- 4.36x
- Price / cash flow
- 12.83x
Enterprise value
- Enterprise value
- $20.9B
- EV / sales
- 3.59x
- EV / EBITDA
- 10.24x
- EV / EBIT
- 11.38x
- Market cap
- $25.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026